Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hideki Shishido is active.

Publication


Featured researches published by Hideki Shishido.


Journal of Cachexia, Sarcopenia and Muscle | 2017

C-reactive protein, symptoms and activity of daily living in patients with advanced cancer receiving palliative care

Koji Amano; Isseki Maeda; Tatsuya Morita; Mika Baba; Tomofumi Miura; Takashi Hama; Ichiro Mori; Nobuhisa Nakajima; Tomohiro Nishi; Hiroki Sakurai; Satofumi Shimoyama; Takuya Shinjo; Hiroto Shirayama; Takeshi Yamada; Shigeki Ono; Taketoshi Ozawa; Ryo Yamamoto; Naoki Yamamoto; Hideki Shishido; Hiroya Kinoshita

The association between C‐reactive protein (CRP) level, symptoms, and activities of daily living (ADL) in advanced cancer patients is unclear.


American Journal of Hospice and Palliative Medicine | 2003

Treatable complications of cancer patients referred to an in-patient hospice

Tatsuya Morita; You Tei; Hideki Shishido; Satoshi Inoue

This paper illustrates the importance of accurate diagnoses and treatments of complications in terminally ill cancer patients. The paper reports on five hospice in-patients who completely recovered from life-threatening complications; three of them had been incorrectly labeled as “imminently dying” by the referring physicians. The paper concludes that it would be beneficial for patients to receive examinations and a trial of medical treatment in their continuing treatment settings.


Cancer | 2017

A prospective, multicenter cohort study to validate a simple performance status-based survival prediction system for oncologists.

Takeshi Yamada; Tatsuya Morita; Isseki Maeda; Satoshi Inoue; Masayuki Ikenaga; Yoshihisa Matsumoto; Mika Baba; Ryuichi Sekine; Takashi Yamaguchi; Takeshi Hirohashi; Tsukasa Tajima; Ryohei Tatara; Hiroaki Watanabe; Hiroyuki Otani; Chizuko Takigawa; Yoshinobu Matsuda; Shigeki Ono; Taketoshi Ozawa; Ryo Yamamoto; Hideki Shishido; Naoki Yamamoto

Survival prediction systems such as the Palliative Prognostic Index (PPI), which includes the Palliative Performance Scale (PPS), are used to estimate survival for terminally ill patients. Oncologists are, however, less familiar with the PPS in comparison with the Eastern Cooperative Oncology Group (ECOG) performance status (PS). This study was designed to validate a simple survival prediction system for oncologists, the Performance Status–Based Palliative Prognostic Index (PS‐PPI), which is a modified form of the PPI based on the ECOG PS.


Journal of Pain and Symptom Management | 2015

Validation of the Simplified Palliative Prognostic Index Using a Single Item From the Communication Capacity Scale

Jun Hamano; Tatsuya Morita; Taketoshi Ozawa; Hideki Shishido; Masanori Kawahara; Shigeru Aoki; Akira Demizu; Masahiro Goshima; Keiji Goto; Yasuaki Gyoda; Kotaro Hashimoto; Sen Otomo; Masako Sekimoto; Takemi Shibata; Yuka Sugimoto; Mikako Matsunaga; Yukihiko Takeda; Jun Nagayama; Hiroya Kinoshita

CONTEXT Although the Palliative Prognostic Index (PPI) is a reliable and validated tool to predict the survival of terminally ill cancer patients, all clinicians cannot always precisely diagnose delirium. OBJECTIVES The primary aim of this study was to examine the predictive value of a simplified PPI. In the simplified PPI, a single item from the Communication Capacity Scale was substituted for the delirium item of the original. METHODS This multicenter prospective cohort study was conducted in Japan from September 2012 through April 2014 and involved 16 palliative care units, 19 hospital-based palliative care teams, and 23 home-based palliative care services. Palliative care physicians recorded clinical variables at the first assessment and followed up patients six months later. RESULTS A total of 2425 subjects were recruited; 2343 had analyzable data. The C-statistics of the original and simplified PPIs were 0.801 and 0.800 for three week and 0.800 and 0.781 for six-week survival predictions, respectively. The sensitivity and specificity for survival predictions using the simplified PPI were 72.9% and 67.6% (for three week) and 80.3% and 61.8% (for six week), respectively. CONCLUSION The simplified PPI showed essentially the same predictive value as the original PPI and is an alternative when clinicians have difficulties in diagnosing delirium.


Palliative Medicine | 2017

Adding items that assess changes in activities of daily living does not improve the predictive accuracy of the Palliative Prognostic Index

Jun Hamano; Yasuharu Tokuda; Shohei Kawagoe; Takuya Shinjo; Hiroto Shirayama; Taketoshi Ozawa; Hideki Shishido; Sen Otomo; Jun Nagayama; Mika Baba; Yo Tei; Shuji Hiramoto; Akihiko Suga; Takayuki Hisanaga; Tatsuhiko Ishihara; Tomoyuki Iwashita; Keisuke Kaneishi; Toshiyuki Kuriyama; Takashi Maeda; Tatsuya Morita

Background: Changes in activities of daily living in cancer patients may predict their survival. The Palliative Prognostic Index is a useful tool to evaluate cancer patients, and adding an item about activities of daily living changes might improve its predictive value. Aim: To clarify whether adding an item about activities of daily living changes improves the accuracy of Palliative Prognostic Index. Design: Multicenter prospective cohort study. Setting: A total of 58 palliative care services in Japan. Participants: Patients aged >20 years diagnosed with locally extensive or metastatic cancer (including hematological neoplasms) who had been admitted to palliative care units, were receiving care by hospital-based palliative care teams, or were receiving home-based palliative care. Palliative care physicians recorded clinical variables at the first assessment and followed up patients 6 months later. Results: A total of 2425 subjects were recruited and 2343 of these had analyzable data. The C-statistic of the original Palliative Prognostic Index was 0.801, and those of modified Palliative Prognostic Indices ranged from 0.793 to 0.805 at 3 weeks. For 6-week survival predictions, the C-statistic of the original Palliative Prognostic Index was 0.802, and those of modified Palliative Prognostic Indices ranged from 0.791 to 0.799. The weighted kappa of the original Palliative Prognostic Index was 0.510, and those of modified Palliative Prognostic Indices ranged from 0.484 to 0.508. Conclusion: Adding items about activities of daily living changes to the Palliative Prognostic Index did not improve prognostic value in advanced cancer patients.


Journal of Pain and Symptom Management | 2004

Olanzapine-induced delirium in a terminally ill cancer patient.

Tatsuya Morita; You Tei; Hideki Shishido; Satoshi Inoue


Journal of Pain and Symptom Management | 2015

The Accuracy of Physicians' Clinical Predictions of Survival in Patients With Advanced Cancer

Koji Amano; Isseki Maeda; Satofumi Shimoyama; Takuya Shinjo; Hiroto Shirayama; Takeshi Yamada; Shigeki Ono; Ryo Yamamoto; Naoki Yamamoto; Hideki Shishido; Mie Shimizu; Masanori Kawahara; Shigeru Aoki; Akira Demizu; Masahiro Goshima; Keiji Goto; Yasuaki Gyoda; Kotaro Hashimoto; Sen Otomo; Masako Sekimoto; Takemi Shibata; Yuka Sugimoto; Tatsuya Morita


Journal of Pain and Symptom Management | 2005

Changes in Medical and Nursing Care in Cancer Patients Transferred from a Palliative Care Team to a Palliative Care Unit

Tatsuya Morita; Chizuru Imura; Koji Fujimoto; Hideki Shishido; Yo Tei; Satoshi Inoue


Journal of Pain and Symptom Management | 2005

Lidocaine Intoxication at Very Small Doses in Terminally Ill Cancer Patients

Yo Tei; Tatsuya Morita; Hideki Shishido; Satoshi Inoue


Journal of Palliative Medicine | 2004

Neuroleptic malignant syndrome after haloperidol and fentanyl infusion in a patient with cancer with severe mineral imbalance.

Tatsuya Morita; Hideki Shishido; Yo Tei; Satoshi Inoue; Kenji Nagayama

Collaboration


Dive into the Hideki Shishido's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hiroaki Watanabe

Tokyo Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Hiroki Sakurai

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Ichiro Mori

Wakayama Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge